Literature DB >> 27730496

Modification in CSF specific gravity in acutely decompensated cirrhosis and acute on chronic liver failure independent of encephalopathy, evidences for an early blood-CSF barrier dysfunction in cirrhosis.

Nicolas Weiss1,2,3, Matteo Rosselli4, Sarah Mouri5,6, Damien Galanaud7, Louis Puybasset8, Banwari Agarwal4, Dominique Thabut5,6, Rajiv Jalan4.   

Abstract

Although hepatic encephalopathy (HE) on the background of acute on chronic liver failure (ACLF) is associated with high mortality rates, it is unknown whether this is due to increased blood-brain barrier permeability. Specific gravity of cerebrospinal fluid measured by CT is able to estimate blood-cerebrospinal fluid-barrier permeability. This study aimed to assess cerebrospinal fluid specific gravity in acutely decompensated cirrhosis and to compare it in patients with or without ACLF and with or without hepatic encephalopathy. We identified all the patients admitted for acute decompensation of cirrhosis who underwent a brain CT-scan. Those patients could present acute decompensation with or without ACLF. The presence of hepatic encephalopathy was noted. They were compared to a group of stable cirrhotic patients and healthy controls. Quantitative brain CT analysis used the Brainview software that gives the weight, the volume and the specific gravity of each determined brain regions. Results are given as median and interquartile ranges and as relative variation compared to the control/baseline group. 36 patients presented an acute decompensation of cirrhosis. Among them, 25 presented with ACLF and 11 without ACLF; 20 presented with hepatic encephalopathy grade ≥ 2. They were compared to 31 stable cirrhosis patients and 61 healthy controls. Cirrhotic patients had increased cerebrospinal fluid specific gravity (CSF-SG) compared to healthy controls (+0.4 %, p < 0.0001). Cirrhotic patients with ACLF have decreased CSF-SG as compared to cirrhotic patients without ACLF (-0.2 %, p = 0.0030) that remained higher than in healthy controls. The presence of hepatic encephalopathy did not modify CSF-SG (-0.09 %, p = 0.1757). Specific gravity did not differ between different brain regions according to the presence or absence of either ACLF or HE. In patients with acute decompensation of cirrhosis, and those with ACLF, CSF specific gravity is modified compared to both stable cirrhotic patients and healthy controls. This pattern is observed even in the absence of hepatic encephalopathy suggesting that blood-CSF barrier impairment is manifest even in absence of overt hepatic encephalopathy.

Entities:  

Keywords:  Blood-brain barrier; Blood-cerebrospinal fluid-barrier; Brain edema; CT scan; Hepatic encephalopathy

Mesh:

Year:  2016        PMID: 27730496     DOI: 10.1007/s11011-016-9916-9

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  37 in total

Review 1.  Choroid plexus transporters for drugs and other xenobiotics.

Authors:  Jean-François Ghersi-Egea; Nathalie Strazielle
Journal:  J Drug Target       Date:  2002-06       Impact factor: 5.121

2.  Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF).

Authors:  Juan Cordoba; Meritxell Ventura-Cots; Macarena Simón-Talero; Àlex Amorós; Marco Pavesi; Hendrik Vilstrup; Paolo Angeli; Marco Domenicali; Pere Ginés; Mauro Bernardi; Vicente Arroyo
Journal:  J Hepatol       Date:  2013-10-12       Impact factor: 25.083

3.  A quantitative computed tomography assessment of brain weight, volume, and specific gravity in severe head trauma.

Authors:  Thomas Lescot; Marie-Pierre Bonnet; Abederrezak Zouaoui; Jean-Charles Muller; Catalin Fetita; Pierre Coriat; Louis Puybasset
Journal:  Intensive Care Med       Date:  2005-07-01       Impact factor: 17.440

Review 4.  Role of phosphate-activated glutaminase in the pathogenesis of hepatic encephalopathy.

Authors:  Manuel Romero-Gómez
Journal:  Metab Brain Dis       Date:  2005-12       Impact factor: 3.584

5.  Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction.

Authors:  C Rose; R F Butterworth; J Zayed; L Normandin; K Todd; A Michalak; L Spahr; P M Huet; G Pomier-Layrargues
Journal:  Gastroenterology       Date:  1999-09       Impact factor: 22.682

6.  Tryptophan and hepatic coma.

Authors:  J Ono; D G Hutson; R S Dombro; J U Levi; A Livingstone; R Zeppa
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

7.  Correlation between ammonia levels and the severity of hepatic encephalopathy.

Authors:  Janus P Ong; Anjana Aggarwal; Derk Krieger; Kirk A Easley; Matthew T Karafa; Frederick Van Lente; Alejandro C Arroliga; Kevin D Mullen
Journal:  Am J Med       Date:  2003-02-15       Impact factor: 4.965

8.  Synergistic effect of bile acid, endotoxin, and ammonia on brain edema.

Authors:  S Tominaga; A Watanabe; T Tsuji
Journal:  Metab Brain Dis       Date:  1991-06       Impact factor: 3.584

9.  Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure.

Authors:  Rajiv Jalan; Faouzi Saliba; Marco Pavesi; Alex Amoros; Richard Moreau; Pere Ginès; Eric Levesque; Francois Durand; Paolo Angeli; Paolo Caraceni; Corinna Hopf; Carlo Alessandria; Ezequiel Rodriguez; Pablo Solis-Muñoz; Wim Laleman; Jonel Trebicka; Stefan Zeuzem; Thierry Gustot; Rajeshwar Mookerjee; Laure Elkrief; German Soriano; Joan Cordoba; Filippo Morando; Alexander Gerbes; Banwari Agarwal; Didier Samuel; Mauro Bernardi; Vicente Arroyo
Journal:  J Hepatol       Date:  2014-06-17       Impact factor: 25.083

Review 10.  Health related quality of life in people with advanced chronic liver disease.

Authors:  James G Orr; Tara Homer; Laura Ternent; Julia Newton; Calum J McNeil; Mark Hudson; David E J Jones
Journal:  J Hepatol       Date:  2014-07-07       Impact factor: 25.083

View more
  5 in total

1.  Understanding hepatic encephalopathy.

Authors:  Nicolas Weiss; Rajiv Jalan; Dominique Thabut
Journal:  Intensive Care Med       Date:  2017-05-25       Impact factor: 17.440

2.  Serum osmolality, cerebrospinal fluid specific gravity and overt hepatic encephalopathy severity in patients with liver failure.

Authors:  Eric M Liotta; Constantine J Karvellas; Minjee Kim; Ayush Batra; Andrew Naidech; Shyam Prabhakaran; Farzaneh A Sorond; W Taylor Kimberly; Matthew B Maas
Journal:  Liver Int       Date:  2020-02-12       Impact factor: 5.828

3.  Bile Acids in Hepatic Encephalopathy.

Authors:  Sharon DeMorrow
Journal:  J Clin Exp Hepatol       Date:  2018-05-04

4.  Neuropsychiatric performance and treatment of hepatitis C with direct-acting antivirals: a prospective study.

Authors:  Sofia Volpato; Sara Montagnese; Alberto Zanetto; Matteo Turco; Michele De Rui; Alberto Ferrarese; Piero Amodio; Giacomo Germani; Marco Senzolo; Martina Gambato; Francesco Paolo Russo; Patrizia Burra
Journal:  BMJ Open Gastroenterol       Date:  2017-12-21

Review 5.  Recent advances in hepatic encephalopathy.

Authors:  Victoria Liere; Gurkarminder Sandhu; Sharon DeMorrow
Journal:  F1000Res       Date:  2017-09-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.